10 results on '"Hamilton-Craig, Christian"'
Search Results
2. Comparison of Whole Heart Computed Tomography Scanners for Image Quality Lower Radiation Dosing in Coronary Computed Tomography Angiography: The CONVERGE Registry.
- Author
-
Patel, Nirali, Li, Dong, Nakanishi, Rine, Fatima, Badiha, Andreini, Daniele, Pontone, Gianluca, Conte, Edoardo, O'Rourke, Rachael, Jayawardena, Eranthi, Hamilton-Craig, Christian, Nimmagadda, Manojna, and Budoff, Matthew J.
- Abstract
Rationale and Objectives: Novel technology in coronary computed tomographic angiography allows assessment of coronary artery disease with high image quality (IQ). There are currently two wide detector "whole heart" coverage scanners available, which avoid misregistration artifacts. However, there are no data directly comparing IQ between the two scanners. The aim of the current study is to investigate if IQ is different between the most scanners of GE and Toshiba broad detector scanners.Materials and Methods: Prospective, observational, multicenter international cohort study comparing 236 consecutive patients who underwent coronary computed tomographic angiography using whole-heart scanners; 126 patients on scanner S1 ( Aquilion ONE Vision, Toshiba), and 110 patients on scanner S2 (Revolution CT, GE Healthcare). Hounsfield units were measured using regions of interest in the descending aorta at 6 points (cranial slice, level of the visualized first, second, third, and fourth spines, and the caudal slice). We also compared the coverage length (z-axis) of the full width field of view between a single rotation of the two scanners.Results: Evaluating mean CT attenuation values Hounsfield units through the scan range, are progressively reduced across the descending aorta in the S1 group, resulting in the larger difference of contrast brightness between the cranial and caudal slices compared to the S2 group (absolute difference: S2 13.0 ± 4.4 vs S1 141.9 ± 16.4, p < 0.0001; Percent difference: 19.3 ± 2.1 vs -3.4 ± 1.2, <0.0001). The standard deviation (SD) is similar at the cranial slice between the two scanners, however, the S1 group demonstrated higher SD-differential from cranial to caudal than S2 group. Median radiation exposure was significantly lower for the S2 scanner 1.50 ± 0.75 mSv vs the S1 system 1.9 mSv (IQR 1.7-2.7 mSv) (p = 0.01). Z-axis coverage was larger for the S2 scanner 152.5 mm (244 slices × 0.625 mm/slice) than 133 mm for S1 (266 slices × 0.5 mm/slice).Conclusion: Although both "volume" scanners cover the whole heart z-axis with one beat, scans using the S1 scanner have a larger variability in attenuation values throughout the scan range, resulting in 20% increase in nonuniformity from cranial to caudal slice. Additionally, SD variation across the field of view, a metric of noise, is larger when using the S1 scanner vs the S2 scanner. These results indicate that the GE Revolution CT has more uniform contrast enhancement and more coverage, lower radiation and lower image noise compared to the Toshiba Aquilion ONE Vision system. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
3. Impact of cardiac magnetic resonance imaging on heart failure patients referred to a tertiary advanced heart failure unit: improvements in diagnosis and management.
- Author
-
Lum, Ying H., McKenzie, Scott, Brown, Martin, and Hamilton‐Craig, Christian
- Subjects
COMPARATIVE studies ,ECHOCARDIOGRAPHY ,HEART failure ,LONGITUDINAL method ,MAGNETIC resonance imaging ,MEDICAL referrals ,MULTIVARIATE analysis ,DECISION making in clinical medicine ,BODY mass index ,MEDICAL records ,RETROSPECTIVE studies ,REVASCULARIZATION (Surgery) ,TERTIARY care ,DIAGNOSIS - Abstract
Background: The clinical use of cardiac magnetic resonance (CMR) in Australian heart failure (HF) patients has limited evidence. Aim: To examine how CMR, compared with routine echocardiography, affects the diagnosis and management of patients with HF. Methods: Single‐centre retrospective study of HF patients newly referred to the Advanced Heart Failure and Transplant unit at The Prince Charles Hospital, Brisbane. Between January 2010 and December 2014, all patients clinically referred for both CMR and echocardiography in the workup of HF were analysed. Imaging results, electronic records and medical charts were reviewed for final diagnosis and changes in clinical management. Results: A total of 114 new HF referrals was included. Evaluation of HF of uncertain aetiology (70%) was the most common indication for CMR. In 20% of cases, CMR led to a completely new diagnosis or diagnostic confirmation of suspicions raised by echocardiography. Clinical decision‐making was altered in 48%, with the greatest impact on decisions regarding revascularisation. Overall, CMR had a significant impact on 50% of patients. In a multivariable model, the only independent variable significantly associated with clinical impact was the presence/absence of late gadolinium enhancement (P < 0.001). Importantly, body mass index, echocardiography image quality and the presence of sinus rhythm did not show statistical significance in the multivariate analysis. Conclusion: CMR makes a substantial contribution to both the diagnosis and management of HF patients over and above standard echocardiography. This study provides evidence of its clinical utility in the HF population in Australia and supports the role of CMR in the routine assessment of this cohort. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
4. Catheter ablation of papillary muscle arrhythmias: Implications of mitral valve prolapse and systolic dysfunction.
- Author
-
Lee, Adam, Hamilton‐Craig, Christian, Denman, Russell, and Haqqani, Haris M.
- Subjects
- *
CARDIOMYOPATHIES , *MYOCARDIUM , *HEART ventricle diseases , *ARRHYTHMIA , *CATHETER ablation , *ECHOCARDIOGRAPHY , *MITRAL valve prolapse , *TREATMENT effectiveness , *VENTRICULAR ejection fraction , *DIAGNOSIS , *SURGERY - Abstract
Abstract: Background: The left ventricular (LV) papillary muscles are important components of the mitral valve apparatus. Catheter ablation of ventricular arrhythmias from these sites is challenging. We aim to describe the association between LV papillary muscle ventricular arrhythmias (VAs) and mitral valve prolapse (MVP), and to determine the outcomes of ablation in these patients with a focus on those with MVP and cardiomyopathy. Methods: A total of 152 patients underwent 170 consecutive procedures for ablation of focal VAs. MVP and cardiomyopathy were diagnosed by echocardiography. Outcomes following ablation were assessed in three groups: (1) LV papillary muscle VAs versus other sites, (2) LV papillary muscle VAs by the presence of MVP, and (3) LV papillary muscle VAs in the setting of cardiomyopathy. Results: Nine of 23 (39%) patients undergoing ablation of LV papillary muscle VAs had MVP compared to none of 129 (0%) patients at other sites (P < 0.001). In the former group, acute procedural success was achieved in 60% and 80% of those with and without MVP, respectively (P = 0.28). Medium‐term outcomes were comparable (P = 0.75). In patients with cardiomyopathy, the median LV ejection fraction improved from 40% to 54% following ablation (P = 0.007). Conclusions: Although MVP is strongly associated with LV papillary muscle VAs, MVP does not adversely affect the acute or medium‐term outcomes of ablation. Systolic function can improve following ablation in patients with ectopy‐mediated cardiomyopathy due to papillary muscle VAs. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
5. Evaluation of aortic regurgitation with cardiac magnetic resonance imaging: a systematic review.
- Author
-
Lee, James C., Branch, Kelley R., Hamilton-Craig, Christian, and Krieger, Eric V.
- Subjects
CARDIAC magnetic resonance imaging ,AORTIC aneurysms ,AORTIC stenosis ,HUMAN abnormalities ,META-analysis ,AORTIC valve ,AORTIC valve insufficiency ,PROSTHETIC heart valves ,MAGNETIC resonance imaging ,MEDICAL care ,PATIENTS ,RESEARCH evaluation ,SYSTEMATIC reviews ,DISEASE progression ,DIAGNOSIS - Abstract
This review summaries the utility, application and data supporting use of cardiac magnetic resonance imaging (CMR) to evaluate and quantitate aortic regurgitation. We systematically searched Medline and PubMed for original research articles published since 2000 that provided data on the quantitation of aortic regurgitation by CMR and identified 11 articles for review. Direct aortic measurements using phase contrast allow quantitation of volumetric flow across the aortic valve and are highly reproducible and accurate compared with echocardiography. However, this technique requires diligence in prescribing the correct imaging planes in the aorta. Volumetric analytic techniques using differences in ventricular volumes are also highly accurate but less than phase contrast techniques and only accurate when concomitant valvular disease is absent. Comparison of both aortic and ventricular data for internal data verification ensures fidelity of aortic regurgitant data. CMR data can be applied to many types of aortic valve regurgitation including combined aortic stenosis with regurgitation, congenital valve diseases and post-transcatheter valve placement. CMR also predicts those patients who progress to surgery with high overall sensitivity and specificity. Future studies of CMR in patients with aortic regurgitation to quantify the incremental benefit over echocardiography as well as prediction of cardiovascular events are warranted. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
6. Quantitation of mitral regurgitation with cardiac magnetic resonance imaging: a systematic review.
- Author
-
Krieger, Eric V., Lee, James, Branch, Kelley R., and Hamilton-Craig, Christian
- Subjects
MITRAL valve insufficiency ,CARDIAC magnetic resonance imaging ,ECHOCARDIOGRAPHY ,QUALITATIVE research ,SYSTEMATIC reviews ,DIAGNOSIS ,HEMODYNAMICS ,MAGNETIC resonance imaging ,MITRAL valve ,PROGNOSIS ,RESEARCH evaluation ,PREDICTIVE tests ,RESEARCH bias ,SEVERITY of illness index ,THERAPEUTICS - Abstract
In this review discuss the application of cardiac magnetic resonance (CMR) to the evaluation and quantification of mitral regurgitation and provide a systematic literature review for comparisons with echocardiography. Using the 2015 Preferred Reporting Items for Systematic Reviews and Meta-Analyses methodology, we searched Medline and PubMed for original research articles published since 2000 that provided data on the quantification of mitral regurgitation by CMR. We identified 220 articles of which 33 were included. Four main techniques of mitral regurgitation quantification were identified. Reproducibility varied substantially between papers but was high overall for all techniques. However, quantification differed between the techniques studied. When compared with two-dimensional echocardiography, mitral regurgitation fraction and regurgitant volume measured by CMR were comparable but typically lower. CMR has high reproducibility for the quantification of mitral regurgitation in experienced centres, but further technological refinement is needed. An integrated and standardised approach that combines multiple techniques is recommended for optimal reproducibility and precise mitral regurgitation quantification. Definitive outcome studies using CMR as a basis for treatment are lacking but needed. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
7. Quantitating aortic regurgitation by cardiovascular magnetic resonance: significant variations due to slice location and breath holding.
- Author
-
Chaturvedi, Abhishek, Hamilton-Craig, Christian, Cawley, Peter, Mitsumori, Lee, Otto, Catherine, Maki, Jeffrey, Cawley, Peter J, Mitsumori, Lee M, Otto, Catherine M, and Maki, Jeffrey H
- Subjects
- *
PHASE contrast magnetic resonance imaging , *HEART valve diseases , *ECHOCARDIOGRAPHY , *PULMONARY artery , *AORTA , *MITRAL valve insufficiency , *AORTIC valve insufficiency , *MAGNETIC resonance imaging , *BREATH holding , *DIAGNOSIS - Abstract
Objectives: Compare variability in flow measurements by phase contrast MRI, performed at different locations in the aorta and pulmonary artery (PA) using breath-held (BH) and free-breathing (FB) sequences.Methods: Fifty-seven patients with valvular heart disease, confirmed by echocardiography, were scanned using BH technique at 3 locations in the ascending aorta (SOV = sinus of Valsalva, STJ = sinotubular junction, ASC = ascending aorta at level of right pulmonary artery) and 2 locations in PA. Single FB measurement was obtained at STJ for aorta. Obtained metrics (SV = stroke volume, FV = forward volume, BV = backward volume, RF = regurgitant fraction) were evaluated separately for patients with aortic regurgitation (AR, n = 31) and mitral regurgitation (n = 26).Results: No difference was noted between the two measurements in the PA. Significant differences were noted in measured SV at different aortic locations. SV measurements obtained at ASC correlated best with the measurements obtained in the PA. Strongest correlation of AR was measured at the STJ.Conclusion: Measurements of flow volumes by phase contrast MRI differ depending on slice location. When using stroke volumes to calculate pulmonary to systemic blood flow ratio (Qp/Qs), ASC should be used. For quantifying aortic regurgitation, measurement should be obtained at STJ.Key Points: • Aortic regurgitation can be accurately measured by MRI. • Aortic regurgitation measurement by MRI varies according to the location where measured. • Aortic regurgitation can also be measured by MRI without breath hold. [ABSTRACT FROM AUTHOR]- Published
- 2016
- Full Text
- View/download PDF
8. Imaging of Scar in Patients with Ventricular Arrhythmias of Right Ventricular Origin: Cardiac Magnetic Resonance Versus Electroanatomic Mapping.
- Author
-
SANTANGELI, PASQUALE, HAMILTON‐CRAIG, CHRISTIAN, RUSSO, ANTONIO DELLO, PIERONI, MAURIZIO, CASELLA, MICHELA, PELARGONIO, GEMMA, BIASE, LUIGI DI, SMALDONE, COSTANTINO, BARTOLETTI, STEFANO, NARDUCCI, MARIA L., TONDO, CLAUDIO, BELLOCCI, FULVIO, and NATALE, ANDREA
- Subjects
- *
HEART function tests , *MAGNETIC resonance imaging , *BIOPSY , *HEART ventricle diseases , *ANALYSIS of variance , *ARRHYTHMIA , *CONFIDENCE intervals , *FISHER exact test , *RIGHT heart ventricle , *CARDIOMYOPATHIES , *SCARS , *T-test (Statistics) , *U-statistics , *RECEIVER operating characteristic curves , *DATA analysis software , *DESCRIPTIVE statistics , *DIAGNOSIS - Abstract
Imaging of Scar in Patients with RV Origin Arrhythmias: CMR Versus EAM. Introduction: Assessment of late gadolinium enhancement (LGE) at cardiac magnetic resonance is often used to detect scar in patients with arrhythmias of right ventricular (RV) origin. Recently, electroanatomic mapping (EAM) has been shown to reliably detect scars corresponding to different cardiomyopathic substrates. We compared LGE with EAM for the detection of scar in patients with arrhythmias of RV origin. Methods and Results: Thirty-one patients with RV arrhythmias and biopsy-proven structural heart disease (18 ARVC and 13 myocarditis), and 5 with idiopathic RV outflow tract arrhythmias underwent LGE analysis and EAM with scar validation through EAM-guided endomyocardial biopsy. EAM scars were present in 23 (64%) patients (all with structural heart disease), whereas LGE was present only in 12 (33%). In 2 cases, EAM provided a false-positive diagnosis of a small scar in the basal perivalvular area. LGE correctly diagnosed EAM scar in 48% of patients, resulting in high positive (92%) but low negative (50%) predictive values. The distribution of LGE was significantly associated with the distribution of EAM scars (P < 0.001 in the free wall, P = 0.003 in the outflow tract, and P = 0.023 in the posterior/inferior wall). Presence of LGE reflected a higher extension of EAM scars (34.4 ± 16.5% vs 7.9 ± 10.1% of the RV area, P < 0.001). At receiver operating characteristic (ROC) analysis, an extension of scar ≥20% of the RV area was the best cut-off value to detect LGE (sensitivity 83%, specificity 92%). Of note, LGE missed 10 of 11 (91%) patients with EAM scars <20% of RV area. Conclusions: LGE is significantly less sensitive than EAM in identifying RV cardiomyopathic substrates. Absence of LGE does not rule out the presence of small scars, and EAM with biopsy should be considered to increase the diagnostic yield. (J Cardiovasc Electrophysiol, Vol. 22, pp. 1359-1366, December 2011) [ABSTRACT FROM AUTHOR]
- Published
- 2011
- Full Text
- View/download PDF
9. Outcomes Following Melody Transcatheter Pulmonary Valve Implantation for Right Ventricular Outflow Tract Dysfunction in Repaired Congenital Heart Disease: First Reported Australian Single Centre Experience.
- Author
-
Markham, Ryan, Challa, Abhinay, Kyranis, Stephen, Nicolae, Mugur, Murdoch, Dale, Savage, Michael, Malpas, Theresa, Radford, Dorothy J, Hamilton-Craig, Christian, and Walters, Darren L
- Subjects
- *
CONGENITAL heart disease , *PULMONARY valve , *CHEMOEMBOLIZATION , *CARDIAC magnetic resonance imaging , *HEALTH outcome assessment , *SURGERY , *THERAPEUTICS , *CARDIAC catheterization , *COMPUTED tomography , *ECHOCARDIOGRAPHY , *PROSTHETIC heart valves , *HEART valve diseases , *HEMODYNAMICS , *LONGITUDINAL method , *TIME , *VENTRICULAR outflow obstruction , *DISEASE complications , *DIAGNOSIS - Abstract
Background: Transcatheter pulmonary valve implantation (TPVI) with the Melody® transcatheter pulmonary valve (TPV) has demonstrated good haemodynamic and clinical outcomes in the treatment of right ventricular outflow tract (RVOT) conduit dysfunction in patients with repaired congenital heart disease CHD. We present the first Australian single centre experience of patients treated with Melody TPV.Method: A prospective, observational registry was developed to monitor clinical and haemodynamic outcomes in patients with RVOT dysfunction treated with the Melody TPV (Medtronic Inc, Minneapolis, United States).Results: Seventeen patients underwent TPVI with Melody TPV at The Prince Charles Hospital between January 2009 and February 2016 with a median (range) age of 34 (R: 15-60). Fifteen (88%) were NYHA Class 2 dyspnoea and 11 (59%) had corrected Tetralogy of Fallot. Indication for TPVI was stenosis in eight (47%), regurgitation in two (12%) and mixed dysfunction in seven (41%). Device implantation was successful in all patients. Peak RVOT gradient was significantly reduced and there was no significant regurgitation post procedure. There was one (6%) major procedural adverse event and two (12%) major adverse events at last recorded follow-up. There were no patient deaths. Follow-up cardiac magnetic resonance imaging revealed a significant reduction in indexed right ventricular end diastolic volume.Conclusion: This study confirms the safety and effectiveness of TPVI with Melody TPV for RVOT dysfunction in repaired CHD. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
10. TAKOTSUBO CARDIOMYOPATHY AND LEFT ATRIAL FUNCTION ASSESSED BY CARDIAC MAGNETIC RESONANCE IMAGING.
- Author
-
Shaw, Elizabeth, Tan, Victoria LC, Ward, Michael, Figtree, Gemma, and Hamilton-Craig, Christian
- Subjects
- *
TAKOTSUBO cardiomyopathy , *HEART disease diagnosis , *MITRAL valve diseases , *CARDIAC magnetic resonance imaging , *HEART physiology , *DIAGNOSIS - Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.